BeLeave

Beleave Update on Stalking Horse Sale Process

Retrieved on: 
Thursday, August 6, 2020
United Kingdom European Union membership referendum, Euroscepticism in the United Kingdom, BeLeave, Stalking horse, Politics

TORONTO, Aug. 6, 2020 /CNW/ - Beleave Inc. (CSE:BE) (OTC: BLEVF) ("Beleave" or the "Company") announced today that the Company, together with its affiliated entities, Beleave Kannabis Corp., Seven Oaks Inc., 9334416 Canada Inc. O/A Medi-Green and My-Grow, Beleave Kannabis Abbotsford Inc. and Beleave Kannabis Chilliwack Inc. (collectively, the "Beleave Group"), and in consultation with Grant Thornton Limited (the "Monitor"), has completed the primary milestone within its Stalking Horse Sale Process.

Key Points: 
  • TORONTO, Aug. 6, 2020 /CNW/ - Beleave Inc. (CSE:BE) (OTC: BLEVF) ("Beleave" or the "Company") announced today that the Company, together with its affiliated entities, Beleave Kannabis Corp., Seven Oaks Inc., 9334416 Canada Inc. O/A Medi-Green and My-Grow, Beleave Kannabis Abbotsford Inc. and Beleave Kannabis Chilliwack Inc. (collectively, the "Beleave Group"), and in consultation with Grant Thornton Limited (the "Monitor"), has completed the primary milestone within its Stalking Horse Sale Process.
  • On June 17, 2020, the Company, in conjunction with the Monitor, commenced the court-approved Stalking Horse Sale Process where Phase 1 Bids were due by July 17, 2020.
  • The Stalking Horse Sale Process targeted 46 potential buyers where additional buyers were added during the process as a result of public advertisement of the sale process.
  • A transaction with the Stalking Horse Purchaser will allow for continued operations of the various Beleave Group operations, as well as employment opportunities.

Beleave CRO Appointment and Approval of Stalking Horse Sale Process

Retrieved on: 
Tuesday, June 16, 2020
Bankruptcy, United Kingdom European Union membership referendum, BeLeave, Euroscepticism in the United Kingdom, Articles, Human behavior, Cannabis, Restructuring, Stalking horse, Legality of cannabis, Humans

The issuance of the Stalking Horse Sale Process Court Order follows the appointment of Bill Panagiotakapoulos as the Company's Chief Restructuring Officer (formerly the Company's Interim CEO and COO) to assist both the Company and the Monitor in respect of the Company's CCAA proceedings which commenced on June 5, 2020, and the Stalking Horse Sale Process which was approved on June 15, 2020.

Key Points: 
  • The issuance of the Stalking Horse Sale Process Court Order follows the appointment of Bill Panagiotakapoulos as the Company's Chief Restructuring Officer (formerly the Company's Interim CEO and COO) to assist both the Company and the Monitor in respect of the Company's CCAA proceedings which commenced on June 5, 2020, and the Stalking Horse Sale Process which was approved on June 15, 2020.
  • The Beleave Group sought creditor protection under the CCAA in order to receive a stay of proceedings that will allow the Beleave Group to facilitate a going concern transaction with Hegedus Consulting Services Inc. (the Stalking Horse Purchaser) or identify and conclude a transaction with a superior offer (the Stalking Horse Sale Process).
  • Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020.
  • Additional enquiries for the Monitor may be directed to:
    In its capacity as proposed Court-appointed Monitor of the Beleave Group.

Beleave Granted Creditor Protection to Pursue Sale of Assets

Retrieved on: 
Friday, June 5, 2020
United Kingdom European Union membership referendum, Euroscepticism in the United Kingdom, BeLeave, Cannabis, Medicine, Medical specialties, Plants

The Initial Order would includes, among other things, a stay of proceedings in favour of the Beleave Group and the appointment of Grant Thornton Limited as monitor of the Beleave Group (in such capacity, the "Monitor").

Key Points: 
  • The Initial Order would includes, among other things, a stay of proceedings in favour of the Beleave Group and the appointment of Grant Thornton Limited as monitor of the Beleave Group (in such capacity, the "Monitor").
  • The Beleave Group sought creditor protection under the CCAA in order to receive a stay of proceedings that will allow the Beleave Group to facilitate a going concern transaction ("Proposed Transaction") with Hegedus Consulting Services Inc. ("Purchaser") or identify and conclude a transaction with a superior offer.
  • Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020.
  • Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Beleave To Seek Creditor Protection to Pursue Sale of Assets

Retrieved on: 
Friday, June 5, 2020
United Kingdom European Union membership referendum, Euroscepticism in the United Kingdom, BeLeave, Cannabis, Medicine, Medical specialties, Plants

The Initial Order being sought would include, among other things, a stay of proceedings in favour of the Beleave Group and the appointment of Grant Thornton Limited as monitor of the Beleave Group (in such capacity, the "Monitor").

Key Points: 
  • The Initial Order being sought would include, among other things, a stay of proceedings in favour of the Beleave Group and the appointment of Grant Thornton Limited as monitor of the Beleave Group (in such capacity, the "Monitor").
  • The Beleave Group is seeking creditor protection under the CCAA in order to receive a stay of proceedings that will allow the Beleave Group to facilitate a going concern transaction ("Proposed Transaction") with Hegedus Consulting Services Inc. ("Purchaser") or identify and conclude a transaction with a superior offer.
  • Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020.
  • Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Beleave Announces Delay in Filing of Audited Financials

Retrieved on: 
Tuesday, July 30, 2019
Euroscepticism in the United Kingdom, United Kingdom European Union membership referendum, Cannabis, Cannabis smoking, BeLeave, Audit, Medicine, Plants, Clinical medicine

Beleave is working to finalize the necessary procedures required by its auditor, and the Company will continue to work diligently to complete the audit as soon as possible.

Key Points: 
  • Beleave is working to finalize the necessary procedures required by its auditor, and the Company will continue to work diligently to complete the audit as soon as possible.
  • "We apologize and understand that this review and delay may cause an inconvenience to our existing and prospective stakeholders," said Beleave's Interim CFO, Kevin Keagan.
  • Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019.
  • Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Beleave Updates Prior Disclosure and Announces Approval of Settlement Agreement with the BCSC

Retrieved on: 
Thursday, June 6, 2019
BeLeave, Euroscepticism in the United Kingdom, United Kingdom European Union membership referendum

Under the terms of the settlement, the BCSC will not seek any orders against the Company, including financial orders.

Key Points: 
  • Under the terms of the settlement, the BCSC will not seek any orders against the Company, including financial orders.
  • Full details of the settlement, including the settlement agreement, will be available on the BCSC website: www.bcsc.bc.ca .
  • The Company's Chief Executive Officer, Bill Panagiotakopoulos commented: "We have cooperated and been fully transparent with the BCSC, and are glad to have arrived at this favourable settlement.
  • Following completion of the special committee's review on or about February 14, 2019, Beleave announced changes to the composition of the Company's management team and Board.

BCSC reaches settlement with company named in the matter of re Bridgemark Financial

Retrieved on: 
Thursday, June 6, 2019
BeLeave, Euroscepticism in the United Kingdom, United Kingdom European Union membership referendum, Private placement, Security

VANCOUVER, June 5, 2019 /CNW/ - The British Columbia Securities Commission (BCSC) has reached a settlement agreement with a cannabis company that participated in conduct that is abusive to B.C.

Key Points: 
  • VANCOUVER, June 5, 2019 /CNW/ - The British Columbia Securities Commission (BCSC) has reached a settlement agreement with a cannabis company that participated in conduct that is abusive to B.C.
  • As part of the settlement agreement, Beleave admitted that it sold $10 million worth of securities through two private placements to the Purported Consultants.
  • The remaining $7.5 million was returned through pre-paid fees to the Purported Consultants, even though they did not provide any services.
  • The company issued news releases saying it had raised $10 million, despite having paid back most of that to the Purported Consultants.

Beleave Receives Unanimous Approval from Hamilton Planning Committee

Retrieved on: 
Wednesday, May 15, 2019
Entheogens, Euphoriants, Medicinal plants, Plants, Cannabis cultivation, Cannabis, BeLeave, Medicine, Human behavior

TORONTO, May 15, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its meeting with the Hamilton Planning Committee on May 14, 2019.

Key Points: 
  • TORONTO, May 15, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its meeting with the Hamilton Planning Committee on May 14, 2019.
  • The committee unanimously approved Beleave's request to rezone their facility in Hamilton, Ontario and will reconvene later this month, through a city council meeting the week of May 20, 2019, to finalize the approval for expansion.
  • Beleave's Hamilton facility continues to provide high-efficiency extraction, R&D, product development and cultivation of cannabis and cannabis derived products throughout this approval process.
  • The Hamilton facility houses growing space for Beleave's line of cannabis products, and continues to be its main hub for extraction, packaging, and distribution.

Beleave Announces Initial Cannabis Oil Sales After Receiving Health Canada Authorization

Retrieved on: 
Monday, April 8, 2019
Euphoriants, Entheogens, Medicinal plants, Cannabis, Psychoactive drugs, Plants, Cannabis smoking, BeLeave, Hash oil

TORONTO, April 8, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary Beleave Kannabis Corp has commenced sales of cannabis oil products at its licensed facility in Hamilton, Ontario.

Key Points: 
  • TORONTO, April 8, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary Beleave Kannabis Corp has commenced sales of cannabis oil products at its licensed facility in Hamilton, Ontario.
  • Beleave has completed its first wholesale transfer of two bulk lots of cannabis oil to another standard processor license holder, as well as having begun cannabis oil product sales to medicinal patients through its online store https://shop.beleave.com .
  • The Company received authorization from Health Canada to sell cannabis oil products in January 2019.
  • Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets.

Beleave Granted Building Permit for Upcoming London Expansion

Retrieved on: 
Friday, April 5, 2019
Euroscepticism in the United Kingdom, United Kingdom European Union membership referendum, BeLeave, Hydro, HVAC

TORONTO, April 5, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has received a Building Permit and moved forward in the Health Canada Licensing process for its facility in London, Ontario.

Key Points: 
  • TORONTO, April 5, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has received a Building Permit and moved forward in the Health Canada Licensing process for its facility in London, Ontario.
  • This includes the installation of 10 megawatts of electrical capacity fully serviced by London Hydro, HVAC, equipment, and site engineering exceeding industry standards.
  • Beleave has invested roughly $8 million in the property to date and, once completed as expected later this year, will provide an additional 115,000 sq.
  • The building permit was granted by the City of London April 1, 2019.